Allstate Corp has a consensus price target of $170.95 based on the ratings of 22 analysts. The high is $200 issued by JP Morgan on July 11, 2024. The low is $108 issued by Barclays on August 14, 2023. The 3 most-recent analyst ratings were released by Goldman Sachs, BMO Capital, and JP Morgan on July 19, 2024, July 18, 2024, and July 11, 2024, respectively. With an average price target of $196.67 between Goldman Sachs, BMO Capital, and JP Morgan, there's an implied 12.78% upside for Allstate Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/19/2024 | Buy Now | 14.12% | Goldman Sachs | Alex Scott | $197 → $199 | Maintains | Buy | Get Alert |
07/18/2024 | Buy Now | 9.53% | BMO Capital | Michael Zaremski | — | Upgrade | Market Perform → Outperform | Get Alert |
07/11/2024 | Buy Now | 14.69% | JP Morgan | Jimmy Bhullar | $193 → $200 | Maintains | Overweight | Get Alert |
07/10/2024 | Buy Now | 14.69% | Morgan Stanley | Michael Phillips | $205 → $200 | Maintains | Overweight | Get Alert |
07/05/2024 | Buy Now | 11.25% | Keefe, Bruyette & Woods | Meyer Shields | $194 → $194 | Maintains | Outperform | Get Alert |
06/21/2024 | Buy Now | 11.25% | Keefe, Bruyette & Woods | Meyer Shields | $194 → $194 | Maintains | Outperform | Get Alert |
05/10/2024 | Buy Now | -12.26% | Wells Fargo | Elyse Greenspan | $146 → $153 | Maintains | Underweight | Get Alert |
05/02/2024 | Buy Now | 10.68% | JP Morgan | Jimmy Bhullar | $185 → $193 | Maintains | Overweight | Get Alert |
04/15/2024 | Buy Now | 8.96% | Morgan Stanley | Michael Phillips | $187 → $190 | Maintains | Overweight | Get Alert |
04/11/2024 | Buy Now | -16.27% | Wells Fargo | Elyse Greenspan | $145 → $146 | Maintains | Underweight | Get Alert |
04/11/2024 | Buy Now | -0.79% | Evercore ISI Group | Oliver Wintermantel | $166 → $173 | Maintains | In-Line | Get Alert |
04/10/2024 | Buy Now | 8.38% | Keefe, Bruyette & Woods | Meyer Shields | $181 → $189 | Maintains | Outperform | Get Alert |
04/08/2024 | Buy Now | 6.09% | JP Morgan | Jimmy Bhullar | $172 → $185 | Maintains | Overweight | Get Alert |
04/08/2024 | Buy Now | 14.69% | Roth MKM | Harry Fong | $175 → $200 | Reiterates | Buy → Buy | Get Alert |
04/01/2024 | Buy Now | 7.81% | Piper Sandler | Paul Newsome | $172 → $188 | Maintains | Overweight | Get Alert |
03/28/2024 | Buy Now | 8.96% | HSBC | Vikram Gandhi | → $190 | Upgrade | Hold → Buy | Get Alert |
03/25/2024 | Buy Now | 11.82% | Goldman Sachs | Alex Scott | $164 → $195 | Maintains | Buy | Get Alert |
02/14/2024 | Buy Now | 3.8% | Keefe, Bruyette & Woods | Meyer Shields | $171 → $181 | Maintains | Outperform | Get Alert |
02/12/2024 | Buy Now | 6.09% | UBS | Brian Meredith | $171 → $185 | Maintains | Buy | Get Alert |
02/09/2024 | Buy Now | -16.85% | Wells Fargo | Elyse Greenspan | $112 → $145 | Maintains | Underweight | Get Alert |
02/08/2024 | Buy Now | -1.36% | JP Morgan | Jimmy Bhullar | $164 → $172 | Maintains | Overweight | Get Alert |
01/22/2024 | Buy Now | 3.22% | Raymond James | C. Gregory Peters | $155 → $180 | Maintains | Strong Buy | Get Alert |
01/19/2024 | Buy Now | -9.39% | BMO Capital | Michael Zaremski | $140 → $158 | Maintains | Market Perform | Get Alert |
01/10/2024 | Buy Now | -1.94% | UBS | Brian Meredith | $160 → $171 | Maintains | Buy | Get Alert |
01/10/2024 | Buy Now | 10.68% | TD Cowen | Andrew Kligerman | → $193 | Initiates | → Outperform | Get Alert |
01/09/2024 | Buy Now | 3.22% | Jefferies | Yaron Kinar | $130 → $180 | Upgrade | Hold → Buy | Get Alert |
01/09/2024 | Buy Now | -5.95% | Goldman Sachs | Alex Scott | $141 → $164 | Maintains | Buy | Get Alert |
01/04/2024 | Buy Now | -1.94% | Morgan Stanley | Michael Phillips | $117 → $171 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/28/2023 | Buy Now | -16.85% | HSBC | Vikram Gandhi | → $145 | Initiates | → Hold | Get Alert |
12/15/2023 | Buy Now | -19.72% | BMO Capital | Michael Zaremski | $125 → $140 | Maintains | Market Perform | Get Alert |
12/07/2023 | Buy Now | -8.25% | UBS | Brian Meredith | $152 → $160 | Maintains | Buy | Get Alert |
11/07/2023 | Buy Now | -19.14% | Goldman Sachs | Alex Scott | $128 → $141 | Maintains | Buy | Get Alert |
11/06/2023 | Buy Now | -11.11% | Raymond James | C. Gregory Peters | $145 → $155 | Maintains | Strong Buy | Get Alert |
11/03/2023 | Buy Now | -20.86% | Piper Sandler | Nicole Miller Regan | $137 → $138 | Maintains | Overweight | Get Alert |
11/03/2023 | Buy Now | -8.25% | Roth MKM | Harry Fong | $145 → $160 | Maintains | Buy | Get Alert |
10/20/2023 | Buy Now | -10.54% | Citigroup | Michael Ward | $135 → $156 | Maintains | Buy | Get Alert |
08/14/2023 | Buy Now | -38.07% | Barclays | Tracy Benguigui | $113 → $107 | Maintains | Equal-Weight | Get Alert |
08/03/2023 | Buy Now | -28.89% | Piper Sandler | Nicole Miller Regan | $137 → $124 | Maintains | Overweight | Get Alert |
08/03/2023 | Buy Now | -16.85% | Raymond James | C. Gregory Peters | $155 → $145 | Maintains | Strong Buy | Get Alert |
08/02/2023 | Buy Now | -11.69% | JP Morgan | Jimmy Bhullar | $162 → $154 | Maintains | Overweight | Get Alert |
08/02/2023 | Buy Now | -32.91% | Morgan Stanley | Michael Phillips | $117 → $117 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
08/01/2023 | Buy Now | -32.91% | Morgan Stanley | Michael Phillips | $117 → $117 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/21/2023 | Buy Now | -21.44% | Piper Sandler | Nicole Miller Regan | $137 → $137 | Reiterates | Overweight → Overweight | Get Alert |
07/21/2023 | Buy Now | -35.2% | Barclays | Tracy Benguigui | $115 → $113 | Maintains | Equal-Weight | Get Alert |
07/06/2023 | Buy Now | -21.44% | Piper Sandler | Nicole Miller Regan | $141 → $137 | Maintains | Overweight | Get Alert |
06/27/2023 | Buy Now | -22.58% | Citigroup | Michael Ward | $138 → $135 | Maintains | Buy | Get Alert |
06/20/2023 | Buy Now | -32.91% | Morgan Stanley | Michael Phillips | → $117 | Initiates | → Equal-Weight | Get Alert |
05/19/2023 | Buy Now | -14.55% | B of A Securities | Joshua Shanker | $146 → $149 | Maintains | Buy | Get Alert |
05/04/2023 | Buy Now | -16.27% | B of A Securities | Joshua Shanker | $147 → $146 | Maintains | Buy | Get Alert |
04/21/2023 | Buy Now | -15.7% | B of A Securities | Joshua Shanker | $145 → $147 | Maintains | Buy | Get Alert |
04/18/2023 | Buy Now | -15.13% | Keefe, Bruyette & Woods | Meyer Shields | $154 → $148 | Maintains | Outperform | Get Alert |
04/18/2023 | Buy Now | -20.86% | Citigroup | Michael Ward | $150 → $138 | Maintains | Buy | Get Alert |
04/12/2023 | Buy Now | -16.85% | B of A Securities | Joshua Shanker | $131 → $145 | Maintains | Buy | Get Alert |
04/12/2023 | Buy Now | -30.04% | Barclays | Tracy Benguigui | $125 → $122 | Maintains | Equal-Weight | Get Alert |
04/05/2023 | Buy Now | -42.65% | Wells Fargo | Elyse Greenspan | $104 → $100 | Maintains | Underweight | Get Alert |
04/04/2023 | Buy Now | -27.74% | Jefferies | Yaron Kinar | $139 → $126 | Maintains | Hold | Get Alert |
04/04/2023 | Buy Now | -13.98% | Piper Sandler | Paul Newsome | $144 → $150 | Maintains | Overweight | Get Alert |
03/29/2023 | Buy Now | -31.18% | BMO Capital | Michael Zaremski | $130 → $120 | Maintains | Market Perform | Get Alert |
03/23/2023 | Buy Now | -24.3% | Evercore ISI Group | Oliver Wintermantel | $138 → $132 | Maintains | In-Line | Get Alert |
02/06/2023 | Buy Now | -9.97% | UBS | Brian Meredith | $160 → $157 | Maintains | Buy | Get Alert |
02/06/2023 | Buy Now | -28.32% | Barclays | Tracy Benguigui | $126 → $125 | Maintains | Equal-Weight | Get Alert |
02/03/2023 | Buy Now | -17.42% | Piper Sandler | Nicole Miller Regan | $153 → $144 | Maintains | Overweight | Get Alert |
02/03/2023 | Buy Now | -40.36% | Wells Fargo | Elyse Greenspan | $105 → $104 | Maintains | Underweight | Get Alert |
02/02/2023 | Buy Now | -18.57% | B of A Securities | Joshua Shanker | $148 → $142 | Maintains | Buy | Get Alert |
02/02/2023 | Buy Now | -20.86% | Evercore ISI Group | David Motemaden | $144 → $138 | Maintains | In-Line | Get Alert |
01/20/2023 | Buy Now | -27.74% | Barclays | Tracy Benguigui | $144 → $126 | Maintains | Equal-Weight | Get Alert |
01/20/2023 | Buy Now | -25.45% | BMO Capital | Michael Zaremski | → $130 | Initiates | → Market Perform | Get Alert |
01/19/2023 | Buy Now | -15.13% | B of A Securities | Joshua Shanker | $154 → $148 | Maintains | Buy | Get Alert |
01/19/2023 | Buy Now | -17.42% | Evercore ISI Group | David Motemaden | $151 → $144 | Maintains | In-Line | Get Alert |
01/19/2023 | Buy Now | -39.79% | Wells Fargo | Elyse Greenspan | $107 → $105 | Maintains | Underweight | Get Alert |
01/18/2023 | Buy Now | -38.64% | Wells Fargo | Elyse Greenspan | $100 → $107 | Maintains | Underweight | Get Alert |
01/10/2023 | Buy Now | -8.25% | UBS | Brian Meredith | $150 → $160 | Maintains | Buy | Get Alert |
01/10/2023 | Buy Now | -12.26% | Piper Sandler | Paul Newsome | $147 → $153 | Maintains | Overweight | Get Alert |
01/09/2023 | Buy Now | -4.81% | Goldman Sachs | Alex Scott | $146 → $166 | Maintains | Buy | Get Alert |
01/04/2023 | Buy Now | -9.97% | JP Morgan | Jimmy Bhullar | $150 → $157 | Maintains | Overweight | Get Alert |
11/22/2022 | Buy Now | -21.44% | Morgan Stanley | Michael Phillips | $140 → $137 | Maintains | Equal-Weight | Get Alert |
11/08/2022 | Buy Now | -26.6% | Barclays | Tracy Benguigui | $112 → $128 | Maintains | Equal-Weight | Get Alert |
11/03/2022 | Buy Now | -13.98% | JP Morgan | Jimmy Bhullar | $152 → $150 | Maintains | Overweight | Get Alert |
10/21/2022 | Buy Now | -25.45% | CFRA | — | $132 → $130 | Downgrade | Buy → Hold | Get Alert |
10/20/2022 | Buy Now | -42.65% | Wells Fargo | Elyse Greenspan | $112 → $100 | Maintains | Underweight | Get Alert |
10/20/2022 | Buy Now | -16.85% | MKM Partners | Harry Fong | $165 → $145 | Maintains | Buy | Get Alert |
10/20/2022 | Buy Now | -35.77% | Barclays | Tracy Benguigui | $127 → $112 | Maintains | Equal-Weight | Get Alert |
10/14/2022 | Buy Now | -27.17% | Barclays | Tracy Benguigui | $120 → $127 | Maintains | Equal-Weight | Get Alert |
10/12/2022 | Buy Now | -35.77% | Wells Fargo | Elyse Greenspan | $110 → $112 | Maintains | Underweight | Get Alert |
10/07/2022 | Buy Now | -22.58% | Jefferies | Yaron Kinar | $129 → $135 | Maintains | Hold | Get Alert |
10/03/2022 | Buy Now | -12.83% | JP Morgan | Jimmy Bhullar | $140 → $152 | Maintains | Overweight | Get Alert |
08/19/2022 | Buy Now | -19.72% | Morgan Stanley | Michael Phillips | $139 → $140 | Maintains | Equal-Weight | Get Alert |
08/15/2022 | Buy Now | -15.13% | Citigroup | Michael Ward | $151 → $148 | Maintains | Buy | Get Alert |
08/08/2022 | Buy Now | -31.18% | Barclays | Tracy Benguigui | $123 → $120 | Maintains | Equal-Weight | Get Alert |
08/04/2022 | Buy Now | -19.72% | JP Morgan | Jimmy Bhullar | $148 → $140 | Maintains | Overweight | Get Alert |
07/27/2022 | Buy Now | -13.41% | Citigroup | Michael Ward | $159 → $151 | Maintains | Buy | Get Alert |
07/21/2022 | Buy Now | -16.27% | Goldman Sachs | Alex Scott | $142 → $146 | Maintains | Buy | Get Alert |
07/21/2022 | Buy Now | -36.92% | Wells Fargo | Elyse Greenspan | $116 → $110 | Maintains | Underweight | Get Alert |
07/21/2022 | Buy Now | -29.46% | Barclays | Tracy Benguigui | $132 → $123 | Maintains | Equal-Weight | Get Alert |
07/21/2022 | Buy Now | -11.11% | Raymond James | C. Gregory Peters | $165 → $155 | Maintains | Strong Buy | Get Alert |
07/12/2022 | Buy Now | -33.48% | Wells Fargo | Elyse Greenspan | $120 → $116 | Maintains | Underweight | Get Alert |
05/24/2022 | Buy Now | -8.82% | Citigroup | Michael Ward | → $159 | Initiates | → Buy | Get Alert |
05/23/2022 | Buy Now | -20.29% | Morgan Stanley | Michael Phillips | $152 → $139 | Maintains | Equal-Weight | Get Alert |
05/20/2022 | Buy Now | — | Argus Research | Kevin Heal | — | Downgrade | Buy → Hold | Get Alert |
05/10/2022 | Buy Now | -22.58% | Jefferies | Yaron Kinar | $133 → $135 | Maintains | Hold | Get Alert |
The latest price target for Allstate (NYSE:ALL) was reported by Goldman Sachs on July 19, 2024. The analyst firm set a price target for $199.00 expecting ALL to rise to within 12 months (a possible 14.12% upside). 42 analyst firms have reported ratings in the last year.
The latest analyst rating for Allstate (NYSE:ALL) was provided by Goldman Sachs, and Allstate maintained their buy rating.
The last upgrade for Allstate Corp happened on July 18, 2024 when BMO Capital raised their price target to $191. BMO Capital previously had a market perform for Allstate Corp.
The last downgrade for Allstate Corp happened on October 21, 2022 when CFRA changed their price target from $132 to $130 for Allstate Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Allstate, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Allstate was filed on July 19, 2024 so you should expect the next rating to be made available sometime around July 19, 2025.
While ratings are subjective and will change, the latest Allstate (ALL) rating was a maintained with a price target of $197.00 to $199.00. The current price Allstate (ALL) is trading at is $174.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.